[PRESS RELEASE – Sydney, New South Wales, Australia, September 20th, 2026]

Monochrome Exchange, a multi-asset trading platform, has announced the Initial Exchange Offering (IEO) of its native utility token, MCR. The platform aims to consolidate crypto, equities, bonds, and real-world assets into a single venue where trades settle on-chain. The exchange is currently live, featuring over 260 active markets.

MCR Initial Exchange Offering Details

• Date: September 21, 13:00 UTC+8 to September 28, 13:00 UTC+8
• Location: Monochrome Launchpad (monochrome.exchange/launchpad)
• Token Price: $0.88 per MCR
• Public Sale Supply: 10,500,000 MCR (5% of total supply)
• Vesting Schedule: 1-month cliff from Token Generation Event (TGE), followed by 3-month linear vesting
• Commitment Asset: USDT
• Subscription Limits: No minimum; maximum of $100,000 per account

The MCR offering will take place directly on the Monochrome Exchange platform. Users can participate by depositing USDT and committing funds on the offering page during the designated seven-day window. Following the one-month cliff after the TGE, MCR tokens will vest linearly and be credited directly to user accounts.

Live Platform Offerings

Monochrome Exchange currently supports trading across four asset classes from a single account balance:

• Crypto: Spot and perpetual markets.
• Equities: Nearly 150 markets, including tokenized exposure to US and Hong Kong equities (e.g., AAPL, NVDA, TSLA, BYD).
• ETFs and Indices: Over 30 options including SPY, QQQ, and XLE.
• Commodities: Gold, silver, platinum, crude oil, Brent, natural gas, and copper.
• Pre-IPO Markets: Tokenized exposure to private companies, including OpenAI and Anthropic.

Leadership and Backing

Monochrome Exchange was founded by Jeff Yew, former Chief Executive Officer of Binance Australia, where he led local operations for the world’s largest cryptocurrency exchange by trading volume. He subsequently founded Monochrome Asset Management, the investment manager behind the first direct-holdings spot Bitcoin ETF of its kind admitted to trading on Cboe under an ASIC-issued Australian Financial Services Licence.

Yew has over a decade of experience across exchange operations, digital asset licensing and the design of regulated investment products. “Tokenisation has produced a large number of assets that barely trade,” said Jeff Yew. “The harder problem has always been the market underneath them: liquidity, settlement, and compliance that holds up. We listed the markets first and are offering the token second.”

Monochrome Exchange operates as a separate entity from Monochrome Asset Management. Jeff Yew’s professional history does not extend any licence, authorisation or regulatory status of any Monochrome affiliate to Monochrome Exchange or to the MCR token.

How It Works

The offering is conducted entirely within the Monochrome Exchange platform. Participation follows four steps:

1. Account. Participants open a Monochrome Exchange account and enable two-factor authentication.
2. Deposit. USDT is deposited to the exchange account. Deposits are credited once confirmed on-chain.
3. Commitment. Funds are committed on the offering page during the seven-day window, which opens on 21 September at 13:00 UTC+8 and closes on 28 September at 13:00 UTC+8, or earlier if the allocation is filled. There is no minimum subscription and a maximum of $100,000 per account.
4. Distribution. MCR is held against the participant’s account from the Token Generation Event. No tokens unlock during the first month. Following the cliff, the allocation vests linearly over three months and is credited automatically as it unlocks.

No external wallet, bridge or on-chain transaction is required at any stage, and no claim transaction is necessary.

MCR Tokenomics and Deflationary Mechanism

The maximum supply of MCR is capped at 210,000,000 tokens. Tokens allocated to the team and advisors are locked for 12 months, followed by a 36-month linear vesting schedule.

$MCR Tokenomics

Vesting Schedule

The token incorporates a buy-back and burn mechanism driven by platform activity:

• 20% of net platform profit will be used to buy back MCR from the open market quarterly.
• 25% of all Launchpad and Digital IPO fee revenue will be added to the buy-back allocation.
• Purchased tokens will be sent to a verifiable burn address to reduce the circulating supply.

Token Utility

MCR serves multiple functions within the Monochrome ecosystem:

• Fee Discounts: Holders receive trading fee discounts ranging from 10% to 50%, tiered by holdings.
• Exclusive Access: MCR acts as the access token for Launchpad offerings and upcoming Digital IPOs, with allocations weighted by user balances.
• Staking: Users can stake MCR to earn rewards, increase allocation weight, and qualify for the node program.
• Governance: Holders can participate in voting on platform listings, Launchpad parameters, and treasury deployment.

Digital IPOs and Leadership

Monochrome Exchange is developing a Digital IPO framework designed to streamline the public listing process by moving issuance, subscription, allocation, and settlement on-chain. MCR will be required to participate in these offerings. The platform schedules its first Digital IPO for Q1 2027.

The exchange was founded by Jeff Yew, former CEO of Binance Australia and founder of Monochrome Asset Management. Yew brings a decade of experience in exchange operations and digital asset licensing. Monochrome Exchange operates as a separate entity from Monochrome Asset Management. Jeff Yew’s professional history does not extend any license, authorization, or regulatory status of Monochrome affiliates to Monochrome Exchange or the MCR token.

About Monochrome

Monochrome Exchange is a multi-asset trading venue where crypto, equities, ETFs, commodities and pre-IPO markets trade from a single account and settle on-chain. The platform currently lists more than 260 markets, including tokenised exposure to US and Hong Kong equities, index and sector ETFs, precious metals and energy, and private companies including OpenAI and Anthropic.

Monochrome Exchange was founded by Jeff Yew, former Chief Executive Officer of Binance Australia and founder of Monochrome Asset Management, the investment manager behind the first direct-holdings spot Bitcoin ETF of its kind admitted to trading on Cboe. MCR is the native utility token of the exchange, used for trading fee discounts, allocation in Launchpad offerings and Digital IPOs, staking and governance.

Monochrome Exchange is a separate entity from Monochrome Asset Management and operates independently of it.

Socials

Website: monochrome.exchange

Twitter: x.com/Monochrome_EN

Disclaimer

MCR is a utility token and does not confer ownership, dividends, profit-sharing, or redemption rights. Digital assets carry significant risks, including total loss. Users are advised to review the full documentation, risk factors, tokenomics, and vesting schedules at docs.monochrome.exchange prior to participation.

The post Multi-Asset Trading Venue Monochrome Exchange Announces IEO of Its Native Token, $MCR appeared first on CryptoPotato.

Source link

Crypto derivatives markets are moving toward two main products, perpetual futures and options. Perpetuals provide continuous leverage, while options are becoming more important for pricing and managing risk.

That shift is also visible in how traders are allocating capital across derivatives. A Glassnode study produced with Bybit found that options increased their share of Bitcoin notional open interest from about 25% to nearly 50%. Meanwhile, dated futures have lost ground in the crypto market.

Options Are Becoming More Important

Dated futures volume is now roughly 97% below its 2021 level, according to the study. Perpetual futures have taken a larger role in leverage, while options have gained ground in volatility trading and hedging.

The growth in options has not been limited to bullish market conditions. Glassnode found that options gained market share in four of the five market regimes it examined since 2019. The largest increase came during a prolonged bear market, when demand for hedging can become more important. This suggests that traders use options not only for directional bets but also to manage risk.

Recent venue data shows that the shift is also changing where Bitcoin options trading takes place. Data through the settled close of August 23, 2026, showed Bybit’s share of options volume across four crypto-native venues rising from below 10% to 28%.

Bybit Expands Its Options Market

Ether has also become an important part of Bybit’s options activity, accounting for 32% of its options volume over the previous 90 days. That was the highest share among the four venues, ahead of OKX at 26%, Binance at 24% and Deribit at 12%.

Bybit also recorded the highest Ether options volume among the four venues for 143 consecutive days. Glassnode measured the lead using both coin and dollar volumes to reduce the effect of changing prices.

The concentration extends beyond crypto assets. Bybit’s tokenized gold perpetual market was the largest among tracked crypto venues for 476 consecutive days, while the platform held 97.1% of gold options open interest.

Bybit’s broader options market has also grown significantly, with its options book rising from $529 million in its first month to $2.33 billion. Growth was uneven, however, as options initially lost share while perpetual activity expanded before recovering.

The post Options Nearly Double Their Share as Crypto Derivatives Market Shifts: Report appeared first on CryptoPotato.

Source link

In crypto, a roadmap can describe what a project wants to build. Public code shows what developers have started to build already. That distinction is especially important for a memecoin launchpad, where users need to know how funding, token supply, refunds, and liquidity are meant to work.

MemeToro has released 1,373 lines of Solidity code across 17 files in its latest update. The project is building an AI-led fair-launch platform on BNB Chain and has raised more than $139,000 in its $0.00430 Stage 7 presale. 

The open-source update gives buyers and developers a clearer view of the proposed system, including its smart-contract rules and the work still required before mainnet deployment.

About MemeToro and its new AI agent on BNB chain

MemeToro is a planned BNB Chain ecosystem for discovering, funding, and trading memecoins. Its main goal is to use an AI agent to research trends and propose launches with documented reasons instead of relying on unverified hype.

Advertisement

The agent is designed to collect social, market, and news evidence. It then prepares a launch manifest that users can read before deciding whether to support a round.

The launch manifest is meant to show the proposed token structure, price, funding cap, and data sources. It gives buyers more information than a standard token announcement.

MemeToro’s validators are designed to reject proposals that fail basic rules. They can reject unsupported URLs, allocation totals that do not equal 100%, insider allocation above zero, and funding terms that conflict with the proposal.

$MT is the planned ecosystem token. It is intended to support access, funding, staking, rewards, memecoin trading, prediction markets, and a news portal.

Advertisement

The project is therefore building both an AI proposal layer and a contract layer. The agent suggests a launch, while smart contracts are meant to enforce the accepted rules.

What a $500 $MT position could look like

At the current $0.00430 Stage 7 rate, $500 would provide about 116,279 $MT before fees. MemeToro’s displayed launch target is $0.05186.

If $MT traded at that level, the allocation would have a theoretical paper value near $6,028, or about 12.06 times the original amount.

At a $1 billion fully diluted valuation, each $MT would be worth about $0.8333 based on the stated 1.2 billion supply. The same $500 allocation could then be worth around $96,899.

Advertisement

These figures are illustrative. They do not account for liquidity limits, slippage, transaction fees, taxes, supply changes, or the risk that $MT trades below the purchase price.

The real opportunity depends on whether MemeToro finishes the product and attracts enough users to make its AI-led fair-launch model valuable after the presale.

The 1,373-line release builds the first contract  layer

The latest update includes 17 files and 1,373 new lines of Solidity code. The main addition is FairLaunchEscrow.sol, a contract designed to hold contributor funds for one memecoin launch round.

The update also introduces ILaunchExecutor.sol. This is the planned plug-in point where future token deployment and liquidity work will connect to the escrow.

A third component, IERC20Minimal.sol, provides the basic token functions needed to support future claim payments. The release also adds documentation, architecture notes, contributor rules, and a full test suite.

Advertisement

The code is built with Foundry, a common Solidity toolkit used for contract development and testing. This allows outside developers to inspect the design and review how the functions are meant to work.

Open-source code does not eliminate risk. It does provide a public trail of development that buyers can compare with the project’s public claims.

The contract design focuses on what cannot happen

MemeToro’s fair-launch draft is designed without an owner, admin role, or upgrade path. This is meant to prevent a team from adding new privileges after a round goes live.

The contract locks round settings at creation. It also stores a fingerprint of the public launch manifest, so users can compare the on-chain terms with the plan they saw before contributing.

Advertisement

The design limits contributor funds to two outcomes: refunds or the planned liquidity process. It does not include a stated route for developer or treasury withdrawals.

The allocation logic is designed to prohibit insider supply. Contributors and liquidity must account for the total supply, while any rounding remainder goes to liquidity.

This is a major part of MemeToro’s bullish case. Instead of saying “trust us, there are no insiders,” the project is publishing code intended to make an insider allocation incompatible with the launch math.

The final system still needs independent review and real-world testing. But the initial contract structure gives the community something concrete to examine.

Advertisement

Tests and remaining milestones show a serious development path

MemeToro’s test suite checks the important launch states: funding caps, deadlines, thresholds, refunds, claims, and unexpected behavior from connected contracts.

Random-sequence testing is also included. This checks that the contract’s accounting remains balanced across many possible transaction orders and that users cannot claim more than they are owed.

The team added two extra tests to ensure the code reaches funded, launched, claimed, and refunded states. That is a useful detail because a passing test is not enough if it never enters the situation it is meant to verify.

The project still needs to complete the real token executor, manifest-to-contract integration, deployment scripts, factory, BNB Chain testnet launch, ERC-8004 agent identity, and independent security review.

Advertisement

MemeToro lists Coinsult, BlockSAFU, and SOLIDProof as audit or review providers. These give buyers three named firms to check alongside the public code and official project updates.

More Information on MemeToro ($MT) Presale Here:

Website: https://memetoro.com/ 

X: https://x.com/memetoro_mt 

Advertisement

Telegram: https://t.me/memetoro_mt 

YouTube: https://www.youtube.com/watch?v=gY0jgWy_DtA 

Source link

Morgan Stanley met privately with Gilead Sciences (GILD) leadership at its 2026 Global Healthcare Conference this month, and the feedback strengthened the bank’s positive view on the stock.

Morgan Stanley’s biopharma team hosted a meeting and a management dinner with Gilead Chairman and CEO Daniel O’Day and Chief Commercial and Corporate Affairs Officer Johanna Mercier. According to a Morgan Stanley research note shared with me, the discussion reinforced its Overweight rating on Gilead and singled out one franchise as the biggest reason to stay positive.

Gilead trades around $150.89, up about 24% year to date and roughly 111% over five years. That kind of run in a biotech stock usually needs a catalyst, and Morgan Stanley points to HIV prevention. The bigger question for investors now is whether the new HIV prevention business built around Yeztugo can keep growing at the pace of the last few quarters.

What Morgan Stanley heard from Gilead’s leadership

Terence Flynn, a Morgan Stanley equity analyst who covers Gilead and other healthcare stocks has held an Overweight rating on the stock since January 2025.

Advertisement

According to the note, Gilead management described the company as being at “an important inflection point, supported by what it views as the most robust portfolio in the company’s history,” with no patent expiring until 2036.

That setup is rare, since most large-cap drugmakers usually spend time preparing for a patent cliff. A patent cliff is what happens when a top-selling drug loses its patent protection and cheaper copies flood the market, which reduces revenue.

Flynn’s price target uses a discounted cash flow model with a 10% weighted average cost of capital and a 3% terminal growth rate, based on the September 15 close of $146.30. The Overweight rating was already in place before the conference, so the note is a confirmation of the existing call.

Gilead earns most of its money from HIV medicines but also sells drugs for hepatitis, oncology, and liver disease. That mix supports cash flow while newer launches ramp up.

Advertisement

Yeztugo is the main reason for Morgan Stanley’s positive view

Yeztugo, the twice-yearly HIV prevention shot Gilead launched in 2025, is the main reason for the bank’s positive view. Yeztugo is a form of PrEP, or pre-exposure prophylaxis, which is a drug people take to prevent HIV infection before they are exposed.

Gilead’s management guided its first full year of Yeztugo sales at approximately $1 billion, with the total prevention portfolio running at about $4 billion annually. According to the note, Yeztugo is drawing “a healthy mix of patients switching from existing PrEP options and individuals entering the category for the first time.”

Story Continues

Advertisement

More Biotech Stocks:

Current PrEP users number roughly 550,000, more than double the 2022 level, while the CDC estimates about 2.2 million Americans could benefit, according to the Morgan Stanley note. That works out to about 25% penetration, and the overall market is growing 14% to 15% each year.

More than 70% of Yeztugo patients returned for their six-month reinjection, which means most patients stayed on the drug long enough to receive full-year protection.

Biktarvy still leads in HIV as new drugs move forward

Yeztugo is the main driver for Gilead’s HIV prevention and treatment business, but Morgan Stanley’s confidence also rests on the wider portfolio.

Biktarvy, Gilead’s flagship HIV treatment pill, still controls more than 50% of the global market and more than two-thirds of patients new to HIV therapy, according to the note. Gilead raised its HIV franchise growth guidance to 9% to 10% for the year, up from 8%. The company recently launched BIC+LEN, a daily oral option built for patients who currently take between five and ten pills a day.

Advertisement

Related: Key HIV stat over 70% leaves BofA siding with Gilead

Beyond HIV, the near-term catalyst that matters most is anito-cel, Gilead’s cell therapy for a type of blood cancer. Gilead’s management continues to describe its profile as “potentially best in disease,” according to the note. 

The Food and Drug Administration has a decision due in December, and Gilead estimates the initial opportunity in advanced-stage patients at approximately $3.5 billion, with plans to move into newly diagnosed patients’ treatment next year.

Two more experimental drugs in immunology and inflammation have late-stage results expected before the end of the year.

Advertisement

The risks investors should watch

Morgan Stanley points to unexpected competition in HIV drugs, execution problems in the HIV pipeline, and the possibility that Kite’s CAR-T cell therapies fail to gain broader market penetration or expand into newly diagnosed patients. CAR-T is a cell therapy that reprograms a patient’s own immune cells to attack cancer.

The Washington policy situation adds another layer of uncertainty. Discussions around pharmacy benefit managers, the 340B drug pricing program, and insurers all touch the HIV franchise, and any of them could affect pricing over the next few years.

For investors who already own the stock, watch the anito-cel FDA decision in December, third- and fourth-quarter Yeztugo sales, and the immunology drug results before year-end.

For anyone who wants to start a new position, Gilead’s 2.17% dividend yield offers some income cushion while these catalysts play out. The stock’s 24% year-to-date rally suggests the easiest entry point has passed, so a gradual accumulation strategy may fit better than a single investment.

Advertisement

Related: Morgan Stanley uncovers major Bristol Myers stock signals

This story was originally published by TheStreet on Sep 20, 2026, where it first appeared in the Investing section. Add TheStreet as a Preferred Source by clicking here.

Advertisement

Source link

Marathon Petroleum Corporation (NYSE:MPC) has substantially outperformed the wider market this year, supported by an unusually sharp surge in global refining margins as the prolonged Iran crisis has significantly tightened global refining capacity and reduced supplies of gasoline, diesel, and jet fuel.

With Marathon up by over 150% since the beginning of 2026, there are now concerns that the stock may have topped out. However, the analysts over at Morgan Stanley are convinced that the rally still has further room to run. On September 14, Morgan Stanley analyst Joe Laetsch significantly raised the firm’s price target on MPC from $265 to $453, while reaffirming an ‘Overweight’ rating on the shares.

The target boost reflects an upside of over 9% from the current price level and even exceeds the stock’s record high of just under $411 per share achieved earlier this month. The Morgan Stanley update comes amid broader Wall Street optimism surrounding the American refining giant, with analysts from Raymon James, UBS, and several others also improving their respective outlooks on MPC.

Cashing In on the Refining Crunch:

Morgan Stanley’s vote of confidence suggests that Wall Street expects the ongoing refining upcycle to last longer than previously expected, especially given the fresh wave of attacks between Washington and Tehran. Even if the conflict in the Middle East subsides, the region’s refined fuel output is expected to remain relatively tight, since the damaged or idled refineries in the Middle East are likely to take some time to return to full operations.

As the largest refiner by volume in the United States, Marathon has significant operating leverage to capitalize on the current high-margin environment. The company already demonstrated its ability to translate the high crack spreads into material earnings when it delivered an almost fourfold increase in profits in the second quarter.

Advertisement

Another major growth engine for Marathon is its stake in MPLX, which owns and operates midstream energy infrastructure. This provides the American refiner with significant exposure to a diversified midstream infrastructure business with relatively stable fee-based income, helping it offset the cyclicality of the refining business.

Marathon Petroleum’s shareholder return strategy also adds to its investment case. The company utilized its elevated cash flows to return $2.8 billion to shareholders during Q2, up from $1 billion in the year-ago period. According to TD Cowen’s Jason Gabelman, the refiner is expected to repurchase about 20% of its market value between Q3 and the end of next year, potentially lifting its per-share earnings.

Source link

Binance Wallet and PancakeSwap have introduced Pre-Access campaigns selling tokenized exposure to private companies before they list publicly. The first project has not been named yet.

The launch extends a year of exchange expansion into traditional assets. Binance has added stock trading, tokenized equities, and pre-IPO derivatives.

But, there’s a catch. Read ahead to find out.

Exchanges Push Further Into Traditional Assets

Demand for on-chain versions of stocks and private shares has pulled several venues in the same direction. Robinhood and Kraken both offer tokenized stock products.

Binance has since moved across the same ground, starting with derivatives. In May, it listed perpetual futures giving users exposure to high-profile private companies ahead of their initial public offerings (IPOs).

The first of those contracts was SPCXUSDT, tied to SpaceX. That company has since completed its Nasdaq listing.

Binance opened US equities trading on June 1. bStocks followed on June 12. 

Demand justifies the pivot. The number of tokenized stockholders reached 3.7 million on September 19, a record, after rising 86% over 30 days. Distributed value also reached a record of over $3 billion, according to RWA.xyz.

Follow us on X to get the latest news as it happens

Binance Pre-IPO Tokens Tie Allocations to Alpha Points

Pre-Access campaigns are the latest addition. Allocations rest on three inputs. Higher Alpha Points and a higher bStocks on-chain tier both increase allocation size, while Trencher Badge holders receive an extra allocation. PancakeSwap sets the final rules, according to Binance’s disclosure.

Binance Wallet framed the launch around access.

“Everyday people have never had access to this kind of early-stage exposure,” it said.

However, the catch is that holders receive no voting rights, dividends, or shareholder rights. Binance also warns that the tokens carry a high degree of risk and may not suit all users. Private company valuations are uncertain, and returns, liquidity, and settlement are not guaranteed.

The post said that the first campaign will be revealed soon. That company’s identity will show whether Pre-Access draws as much demand as the perpetuals did.

Subscribe to our YouTube channel to watch leaders and journalists provide expert insights

The post You Can Soon Get Pre-IPO Exposure on Binance Wallet, But There's A Catch appeared first on BeInCrypto.

Source link

Mainstream AI models failed 57% of personal finance answers, according to UK fintech firm Saturn. Failure rates climbed to 88% on harder, multi-step queries.

The results came as consumer reliance on chatbots for money questions has grown sharply.

Harder Questions Broke Almost Every Model

The study ran 121 questions through 18 free and paid models from providers including ChatGPT, Gemini, Claude, and Copilot. Each question was repeated up to 5 times, producing more than 10,000 answers.

The test scored an answer as a failure when it contained a factual error, skipped something material, or omitted a required warning.

Free models performed the worst, failing on 63% of answers compared to 49% for paid versions. On the hardest questions, free models failed 93% of the time.

Claude Opus 5 in reasoning mode led the field. However, it still failed 39% of answers. The errors included miscalculations, overlooked tax changes, and nonexistent rules. 

One pension tax answer could have exposed a saver to a £17,500 charge from HM Revenue and Customs.

“Millions of people are trusting the AI models for money advice, but they are getting wrong answers that can lose them money,” Amal Jolly, Saturn chief executive, said.

Follow us on X to get the latest news as it happens

Trust in AI Chatbots Keeps Climbing Anyway

Meanwhile, usage has widened across markets and age groups. A global EY survey of 18,000 consumers found that 49% had used AI to support savings and investment decisions.

Britain’s financial regulator reported in August that four in five less experienced investors have used AI for help with investing. Of those surveyed, 56% said they trust the tools, ahead of television and radio at 47%.

Meanwhile, the same research found 44% wrongly believe AI-generated financial information is regulated.

A PensionBee survey of 1,000 US adults found nearly six in ten would act on money guidance without independently checking it. Nearly one in four said a chatbot had already given them wrong information about their finances.

Jolly said AI financial advice is unregulated, leaving consumers without the compensation rights a human adviser would carry. He urged the FCA to act quickly. 

Subscribe to our YouTube channel to watch leaders and journalists provide expert insights

The post Should You Trust a Chatbot With Your Money? A 10,000-Answer Test Has a Verdict appeared first on BeInCrypto.

Source link

Moreover, Delta continues to grow its highly successful loyalty-related revenue alongside remuneration from co-branded credit cards with American Express (management expects to grow 10% to $9 billion in 2026). This is high-quality revenue, as SkyMiles is paid for up front and is less tied to flying volume.

Higher-quality earnings

While Delta is never really going to escape cyclical exposure, that exposure is a lot less than many investors think. Trading at just 12.4 times 2026 earnings estimates, the stock looks like an excellent value, with plenty of revenue streams (premium, loyalty, credit cards, etc.) that hold up well in a slowdown.

All told, Delta is improving the quality of its earnings, including its resilience during a slowdown. That’s good news for investors.

Advertisement

Should you buy stock in Delta Air Lines right now?

Before you buy stock in Delta Air Lines, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Delta Air Lines wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004… if you invested $1,000 at the time of our recommendation, you’d have $387,158!* Or when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $1,365,749!*

Now, it’s worth noting Stock Advisor’s total average return is 932% — a market-crushing outperformance compared to 211% for the S&P 500. Don’t miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

Advertisement

See the 10 stocks »

*Stock Advisor returns as of September 20, 2026.

American Express is an advertising partner of Motley Fool Money. Lee Samaha has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends American Express. The Motley Fool recommends Delta Air Lines. The Motley Fool has a disclosure policy.

Delta’s Non-Main-Cabin Revenue Hits 61% in 2026 — Why It Matters for Earnings was originally published by The Motley Fool

Advertisement

Source link

Gemini Space Station (GEMI), a crypto platform, has seen its price roughly 80% since its public debut, reviving questions about whether the platform founded by the billionaire Winklevoss twins could eventually become an acquisition target.

Lorenzo Valente, director of digital assets research at ARK Invest, argued in a post on X last month that Hyperliquid, the offshore perpetual-trading platform, should acquire Gemini and use it as a regulated U.S. gateway for perpetual futures and prediction markets, with the Winklevoss twins’ concentrated voting control potentially simplifying the deal.

Is Gemini a viable target?

While there is no indication that Hyperliquid is actively pursuing a deal to buy Gemini, Valente’s proposal raises a broader question: What is Gemini’s value proposition to a potential buyer if its regulatory infrastructure is worth more than its shrinking spot-exchange business?

Currently, the stock’s market cap is $753 million, down from about $4 billion at its peak. Gemini’s second-quarter exchange revenue fell 38% from a year earlier to $12.5 million, while spot trading volume dropped 66% to $3.8 billion, and assets on the platform declined to $8.4 billion from $18.2 billion.

Source link

After a couple of consecutive weeks in which the spot XRP ETFs attracted nearly $19 million, the actual inflows were slashed in half during the previous, highly eventful five-day trading period.

Nevertheless, they have extended their green streak, which can also be said of the spot SOL ETFs. In fact, the Solana funds have been in the green for nearly three months now.

XRP ETFs Hit New ATH

On the day ahead of the crucial Senate vote for the CLARITY Act, the spot Ripple ETFs attracted $11.26 million, which helped them start the week with a bang. Interestingly, the failure of the bill vote on Tuesday didn’t result in any direct net outflows, with SoSoValue showing $0.00 in reportable data on that day, even though the underlying asset slumped by more than 8% in hours.

In fact, investors continued to pour funds into the financial vehicle on the next day, with $3.50 million entering the ETFs despite the Fed’s rate hike on Wednesday. That’s where the tide turned, and the net inflows stopped. SoSoValue shows $5.15 million in net withdrawals completed on Thursday, and a very modest $43,700 taken out on Friday.

As such, the cumulative total net inflows reached a new all-time high on Wednesday at $1.720 billion but dropped toward $1.710 billion a day later. Nevertheless, the week was still a success, with $9.56 million in net inflows. The last time the spot XRP ETFs were in the red was during the first full week of July.

SOL ETFs Are Doing Even Better

Similar to the XRP ETFs, the SOL counterparts began the week on a high note, attracting just over $11 million. They didn’t budge on Tuesday either, gaining another $1.35 million. The net inflows slowed down to under $840,000 on Wednesday and went to $0.00 on Thursday. As of press time, there’s no data on SoSoValue about what happened on Friday, so we will assume it was another non-action day of $0.00.

Given the currently available information, the week ended with $13.19 million in net inflows. Unless investors pulled out over that amount on Friday alone, which is highly unlikely since the last time this happened was on July 28, then the green streak of consecutive weeks with more net inflows grew to 12. In other words, the last time the SOL ETFs were in the red weekly was in late June.

Meanwhile, the underlying asset rocketed to a multi-month peak of around $115 during the Friday/Saturday rally, before it was rejected to below $110 as of Sunday afternoon.

The post Ripple (XRP) ETFs Hit 10-Week Green Streak, but Solana (SOL) Funds Go Even Further appeared first on CryptoPotato.

Source link